Search results for "Marker"

showing 10 items of 3799 documents

Helicobacter pylori and atrial fibrillation: absence of correlations

2009

Malemedicine.medical_specialtyRisk AssessmentGastroenterologyHelicobacter InfectionsRisk FactorsInternal medicineAtrial FibrillationmedicineHumansProspective StudiesProspective cohort studyHelicobacter pyloribiologybusiness.industryCase-control studyAtrial fibrillationGeneral MedicineMiddle AgedHelicobacter pylorimedicine.diseaseHelicobacter Infectionsbiology.organism_classificationInflammatory mediatorHelicobacter pylori atrial fibrillationCase-Control StudiesFemaleInflammation MediatorsCardiology and Cardiovascular MedicineRisk assessmentbusinessBiomarkersJournal of Cardiovascular Medicine
researchProduct

Benefits of Statin Therapy Based on Plasma Carbohydrate Antigen 125 Values Following an Admission for Acute Heart Failure

2011

The prognostic benefit of statins in patients with heart failure is a topic of controversy. Under the hypothesis that statins may provide greater benefit in a subgroup of patients with heightened inflammatory activity, we sought to explore whether statins are associated with a decreased risk of long-term mortality in patients with acute heart failure based on elevated levels of carbohydrate antigen 125, a biomarker related to systemic congestion and proinflammatory status.We analysed 1222 consecutive patients admitted with acute heart failure in a single teaching center during a median follow-up of 20 months. carbohydrate antigen 125 was measured during index hospitalization and dichotomize…

Malemedicine.medical_specialtyRisk AssessmentProinflammatory cytokineCohort StudiesElectrocardiographyCause of DeathInternal medicinemedicineHumansProspective StudiesIntensive care medicineProspective cohort studyAgedCause of deathAged 80 and overHeart Failuremedicine.diagnostic_testbusiness.industryGeneral MedicineMiddle AgedPrognosismedicine.diseaseCardiovascular DiseasesCA-125 AntigenHeart failureAcute DiseaseBiomarker (medicine)FemaleHydroxymethylglutaryl-CoA Reductase InhibitorsRisk assessmentbusinessElectrocardiographyBiomarkersFollow-Up StudiesCohort studyRevista Española de Cardiología (English Edition)
researchProduct

Vitamin C supplementation does not improve hypoxia-induced erythropoiesis.

2012

Martinez-Bello,Vladimir E., Fabian Sanchis-Gomar, Daniel Martinez-Bello, Gloria Olaso-Gonzalez, Mari Carmen Gomez-Cabrera, and Jose Viña. Vitamin C Supplementation Does Not Improve Hypoxia-Induced Erythropoiesis. High Alt Med Biol 13:269–274, 2012.—Hypoxia induces reactive oxygen species production. Supplements with antioxidant mixtures can compensate for the decline in red cell membrane stability following intermittent hypobaric hypoxia by decreasing protein and lipid oxidation. We aimed to determine whether supplementation with vitamin C is implicated in the regulation of erythropoiesis and in the oxygen-carrying capacity of the blood, and also whether antioxidant supplementation prevents…

Malemedicine.medical_specialtyScientific ArticlesAntioxidantPhysiologymedicine.medical_treatmentAscorbic AcidHematocritBiologyProtein oxidationAntioxidantsDrug Administration ScheduleRandom AllocationLipid oxidationInternal medicineMalondialdehydemedicineAnimalsErythropoiesisRats WistarHypoxiaHematologic Testsmedicine.diagnostic_testVitamin CPublic Health Environmental and Occupational HealthIntermittent hypoxiaGeneral MedicineBlood ProteinsHypoxia (medical)RatsOxidative StressEndocrinologyBiochemistryDietary SupplementsErythropoiesismedicine.symptomOxidation-ReductionBiomarkersHigh altitude medicinebiology
researchProduct

Designing a new scoring system (QualyP Score) correlating the management of cardiopulmonary bypass to postoperative outcomes

2014

Aim: The aim of this study was to ascertain if a score, directly derived from CPB records, could correlate to major postoperative outcomes. Methods: An additive score (QualyP Score) was created from 10 parameters: peak lactate value during CPB, peak VCO2i, lowest DO2i/VCO2i, peak respiratory quotient, CPB time, cross-clamp time, lowest CPB temperature, circulatory arrest, ultrafiltration during CPB, number of packed red cells transfused intraoperatively. The PerfSCORE was calculated, as well. Multivariable logistic regression models were built to detect the independent predictors of: peak lactate >3 mmol/L during the first three postoperative days; the incidence of acute kidney injury ne…

Malemedicine.medical_specialtyScoring systemrisk scoreperfusionlaw.inventionPostoperative ComplicationsPredictive Value of TestslawCardiopulmonary bypassHumansMedicineRadiology Nuclear Medicine and imagingLactic AcidProspective StudiesIntensive care medicineAgedRetrospective StudiesAdvanced and Specialized NursingCardiopulmonary BypassFramingham Risk Scorebusiness.industryGeneral MedicineCarbon DioxideMiddle AgedqualityFemaleCardiology and Cardiovascular MedicinebusinessSafety ResearchBiomarkers
researchProduct

Circulating adiponectin: a cardiometabolic marker associated with global cardiovascular risk

2015

OBJECTIVE This study was designed to evaluate the relationship among circulating adiponectin (ADPN), left ventricular mass (LVM) and cardiometabolic comorbidities in subjects at higher global cardiovascular risk (score of “ Cuore Project “) METHODS. 115 consecutive subjects were grouped according to normal or low ADPN levels. Left ventricular internal diameter (LVID/h), total LV mass (LVM), LVM index (LVMI), relative wall thickness (RWT), LV ejection fraction by echocardiography and diastolic parameters, by pulsed-wave Doppler were calculated. RESULTS Low-ADPN subjects were characterized by a significant higher prevalence of some cardiometabolic comorbidities (obesity, visceral obesity, dia…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaCardiac VolumeHeart VentriclesCardiac VolumeLeft ventricular hypertrophyRisk AssessmentVentricular Function LeftLeft ventricular massRisk FactorsInternal medicinePrevalencemedicineHumansEchocardiography Doppler PulsedVentricular functionAdiponectinbusiness.industryStroke VolumeAdiponectinGlobal cardiovascular riskleft ventricular hypertrophyGeneral MedicineStroke volumeMiddle AgedPrognosismedicine.diseaseItalyCardiovascular DiseasesCardiologyFemaleAdiponectinCardiology and Cardiovascular MedicinebusinessBiomarkersActa Cardiologica
researchProduct

The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk

2021

Abstract Introduction Serum uric acid (SUA) has been depicted as a contributory causal factor in metabolic syndrome (MS), which in turn, portends unfavourable prognosis. Aim We assessed the prognostic role of SUA in patients with and without MS. Methods We used data from the multicentre Uric Acid Right for Heart Health study and considered cardiovascular mortality (CVM) as death due to fatal myocardial infarction, stroke, sudden cardiac death, or heart failure. Results A total of 9589 subjects (median age 58.5 years, 45% males) were included in the analysis, and 5100 (53%) patients had a final diagnosis of MS. After a median follow-up of 142 months, we observed 558 events. Using a previousl…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaCardiovascular mortalityPrognosiSudden cardiac deathchemistry.chemical_compoundSerum uric acidRisk FactorsInternal medicineCause of DeathmedicineHumansSerum uric acid.Myocardial infarctionCardiovascular mortality; Metabolic syndrome; Prognosis; Serum uric acidStrokeRetrospective StudiesOriginal Paperbusiness.industryProportional hazards modelHazard ratioGeneral MedicineMiddle Agedmedicine.diseasePrognosisMetabolic syndromeUric AcidSurvival RatechemistryItalyCardiovascular DiseasesHeart failureCardiologyUric acidFemaleMetabolic syndromeCardiology and Cardiovascular MedicinebusinessBiomarkersFollow-Up Studies
researchProduct

The predictive role of C-reactive protein in patients with hypertension and subclinical atherosclerosis.

2009

Recent guidelines published by the joint European Society of Hypertension/European Society of Cardiology have suggested the inclusion of C-reactive protein (CRP) in the standard assessment of cardiovascular risk in hypertensive patients, but little data is available on the role of CRP in patients with carotid lesions. We studied in 472 subjects, 236 with and 236 without hypertension, gender- and age-matched, with and without early stages of atherosclerosis (e.g. those with asymptomatic intima-media thickness >0.9 mm), the influence of all the other traditional cardiovascular risk factors (e.g. older age, male gender, obesity, diabetes, smoking habit, family history of coronary artery diseas…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaInflammationAsymptomaticCoronary artery diseasePredictive Value of TestsRisk FactorsInternal medicineDiabetes mellitusCRP Hypertension Subclinical Atherosclerosis atherosclerosisInternal MedicinemedicineHumansIn patientFamily historyAgedbiologybusiness.industryC-reactive proteinMiddle Agedmedicine.diseaseC-reactive protein hypertension inflammation event atherosclerosisAtherosclerosisObesitySettore MED/11 - Malattie Dell'Apparato CardiovascolareCerebrovascular DisordersC-Reactive ProteinCase-Control StudiesHypertensionCardiologybiology.proteinFemalemedicine.symptombusinessBiomarkersFollow-Up StudiesInternal medicine journal
researchProduct

Blood urea nitrogen to creatinine ratio is associated with congestion and mortality in heart failure patients with renal dysfunction

2015

Renal dysfunction (RD) and venous congestion are related and common in heart failure (HF). Studies suggest that venous congestion may be the primary driver of RD in HF. In this study, we sought to investigate retrospectively the relationship between common measures of renal function with caval congestion and mortality among outpatients with HF and RD. We reviewed data from 103 HF outpatients (45 males, mean age 74 years, ejection fraction 41.8 ± 11.6 %) with estimated glomerular filtration rate (eGFR) of 25.5 (adjusted OR 2.98, p 0.015) and eGFR ≤45.8 (adjusted OR 5.38, p 0.002) identify patients at risk for caval congestion; a BUN/Cr >23.7 was the best predictor of impaired collapsibility …

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaRenal functionHyperemiaVena Cava InferiorHeart failureInferior vena cavaNyha classBlood Urea NitrogenCollapse index; Congestion; Heart failure; Inferior vena cava; Outpatients; Renal dysfunctionchemistry.chemical_compoundRisk FactorsInternal medicineInternal MedicinemedicineHumansRenal InsufficiencyInferior vena cavaBlood urea nitrogenAgedRetrospective StudiesCreatinineEjection fractionbusiness.industryOutpatientRetrospective cohort studymedicine.diseaseItalymedicine.veinchemistryCreatinineHeart failureCongestionEmergency MedicineCardiologyRenal dysfunctionFemaleCollapse indexbusinessBiomarkersGlomerular Filtration RateInternal and Emergency Medicine
researchProduct

Influence of HMG-CoA reductase inhibitors on markers of coagulation, systemic inflammation and soluble cell adhesion.

2002

Abstract Background: Beneath its lipid-lowering properties additional non-lipid effects of statin therapy are discussed. We therefore examined the impact of statins on laboratory markers of coagulation, inflammation and soluble cell adhesion to further explore these effects in 950 hospitalised patients with angiographically proven CAD. Methods and results: Although no significant differences were found in total cholesterol, LDL and HDL and triglyceride levels a statistically lower value in 277 statin-treated patients was found for von Willebrand factor [162(130/224) vs. 208(154/283)%, P =0.0001], leukocyte count [6.9(5.8/8.4) vs. 7.3(6.1/9.4)/nl, P =0.0005], high sensitive CRP [4.3(1.8/10.8…

Malemedicine.medical_specialtyStatinmedicine.drug_classInflammationCoronary Artery DiseaseSystemic inflammationchemistry.chemical_compoundVon Willebrand factorInternal medicinevon Willebrand FactormedicineCell AdhesionHumansAgedbiologyTriglycerideCholesterolbusiness.industryAnticholesteremic AgentsCholesterol LDLMiddle AgedEndocrinologyCoagulationchemistryHMG-CoA reductasebiology.proteinFemalemedicine.symptomHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessBiomarkersInternational journal of cardiology
researchProduct

Low-Frequency Electrical Stimulation Increases Muscle Strength and Improves Blood Supply in Patients With Chronic Heart Failure

2005

This study was designed to evaluate the effects of low-frequency electrical stimulation (LFES) on muscle strength and blood flow in patients with advanced chronic heart failure (CHF).Patients with CHF (n=15; age 56.5 +/- 5.2 years; New York Heart Association III - IV; ejection fraction 18.7 +/- 3.3%) were examined before and after 6 weeks of LFES (10 Hz) of the quadriceps and calf muscles of both legs (1 h/day, 7 days/week). Dynamometry was performed weekly to determine maximal muscle strength (F(max); N) and isokinetic peak torque (PT(max); Nm); blood flow velocity (BFV) was measured at baseline and after 6 weeks of LFES using pulsed-wave Doppler velocimetry of the right femoral artery. Si…

Malemedicine.medical_specialtyStimulation030204 cardiovascular system & hematologyVentricular Function LeftBody Mass Index03 medical and health sciences0302 clinical medicineCoronary CirculationInternal medicineHumansMedicineIn patientMuscle SkeletalHeart FailureVentricular functionbusiness.industryHeartGeneral MedicineBlood flowMiddle Agedmedicine.diseaseElectric StimulationC-Reactive ProteinChronic diseaseHeart failureChronic DiseaseCardiologyMuscle strengthFemaleBlood supplyShear StrengthCardiology and Cardiovascular MedicinebusinessBiomarkersBlood Flow Velocity030217 neurology & neurosurgeryCirculation Journal
researchProduct